Chitosan Modification-Enhanced Silencing Effect of Ad5-shPDGF-D Vector in Breast Cancer Cell Line MDA-MB-231

Area of Science:

• Biotechnology
• Gene Therapy
• Nanomedicine

Background:

• Metastatic breast tumors often resist conventional treatments, necessitating novel therapeutic strategies.
• Platelet-derived growth factor-D (PDGF-D) is a key target due to its role in tumor angiogenesis and growth.
• Developing effective delivery vectors is crucial for gene therapy success, as viral and nonviral methods have limitations.

Purpose of the Study:

• To create a recombinant adenovirus type-5 (Ad5)/chitosan hybrid vector for delivering short hairpin RNA targeting PDGF-D (shPDGF-D).
• To investigate the noncovalent coating of Ad5 with chitosan for enhanced gene delivery in a breast cancer cell line.

Main Methods:

• Prepared Ad5/chitosan hybrid vectors using different molecular weights and amounts of chitosan.
• Coated Ad5 particles noncovalently with chitosan.
• Evaluated PDGF-D silencing efficiency in MDA-MB-231 breast cancer cells.

Main Results:

• Chitosan coating modified Ad5 particle size and surface charge.
• Both low and high molecular weight chitosan improved PDGF-D silencing efficiency compared to Ad5 alone.
• Low-molecular-weight chitosan offered faster silencing, while high-molecular-weight chitosan provided sustained silencing.

Conclusions:

• Noncovalent modification of Ad5 with chitosan enhances its gene silencing capabilities.
• This hybrid vector shows promise for improving therapeutic efficacy in breast cancer gene therapy.
• Further in vitro and in vivo studies are warranted to explore the full therapeutic potential.